Skip to main content
. 2019 Jan 31;37(8):624–635. doi: 10.1200/JCO.18.00636

FIG 2.

FIG 2.

Kaplan-Meier combined survival curves for the association between PTGS2 expression and treatment arm in the estrogen receptor (ER)–negative population. (A) Event-free survival (EFS) by PTGS2 expression and celecoxib use; (B) overall survival (OS) by PTGS2 expression and celecoxib use. ITT, intention to treat.